Leukemia-Lymphoma, Adult T-Cell - 25 Studies Found
Completed |
: Phase II Study of the Efficacy and Toxicity of Ontak(Registered Trademark) (Denileukin Diftitox) in the Therapy of Adult T-Cell Leukemia : Leukemia, Adult T-Cell : 2005-07-07 : Biological: Denileukin diftitox (Ontak) Patients will be treated with Denileukin Diftitox 9 mcg/kg/d int |
Completed |
: Study of Adult T-Cell Leukemia/Lymphoma Among Carriers of HTLV-1 : Human T-Lymphoma Virus Type I : 2006-06-19 |
Recruiting |
: High Risk Adult T-cell Leukemia/Lymphoma (ATLL-HR) and Allogeneic Transplant :
: 2013-09-03 |
Completed |
: Campath-1H for Treating Adult T-Cell Leukemia/Lymphoma : Acute T-Cell Leukemia-Lymphoma : 2003-05-20 : Biological: Alemtuzumab Infusion of Campath-1H 3 mg on day # 1, 10 mg on day #2, and 30 mg day # 3 follo |
Terminated |
: Zidovudine, Interferon Alfa-2b, and PEG-Interferon Alfa-2b in Treating Patients With Human T-Cell Lymphotropic Virus Type 1-Associated Adult T-Cell Leukemia/Lymphoma :
: 2009-02-28 :
|